Co-Diagnostics, Inc. Common Stock
CODX XNAS
$3.23
+0.00 (+0.00%)
▲
15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$11.90M
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $146.0K | $-9,140,038 | $-4.06 |
| FY 2025 | $622.5K | $-46,895,936 | $-35.25 |
| Q3 2025 | $145.4K | $-5,886,823 | $-0.16 |
| Q2 2025 | $162.9K | $-7,730,117 | $-0.23 |
Earnings & Analyst Ratings
Next Earnings:
Wed, Aug 12, 2026
Calendar →
TickerDaily Coverage
Why Is Co-Diagnostics, Inc. Common Stock (CODX) Stock Up 57.3% Today?
Market News
Alex Chen · May 28, 2026
Co-Diagnostics (CODX) stock exploded 57.3% higher Thursday, jumping from $7.30 to $11.49 on massive...
Why Is Co-Diagnostics, Inc. Common Stock (CODX) Stock Up 65.1% Today?
Market News
Alex Chen · May 26, 2026
Co-Diagnostics (CODX) exploded 65.1% higher to $8.37 on Tuesday, May 26, driven by full year 2025...
Why Is Co-Diagnostics, Inc. Common Stock (CODX) Stock Up 60.4% Today?
Penny Stocks
Marcus Rivera · May 19, 2026
Co-Diagnostics (CODX) exploded 60.4% higher Tuesday, May 19, 2026, following the release of full...
View All Coverage →
Get CODX Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Co-Diagnostics, Inc. Common Stock.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.